An Observational Cohort Study on Transplant-Related Mortality in Patients Receiving Either a Hematopoietic Stem Cell Transplantation Without ATIR or an Umbilical Cord Blood Transplantation
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 08 Oct 2015
Price : $35 *
At a glance
- Drugs T cell replacement therapy (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- Sponsors Kiadis Pharma
- 05 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Mar 2015 Planned End Date changed from 1 Jan 2015 to 1 May 2015 as reported by ClinicalTrials.gov record.
- 17 Mar 2015 Planned primary completion date changed from 1 Jan 2015 to 1 May 2015 as reported by ClinicalTrials.gov record.